| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014191 Treatment of Protein Misfolding |
| 01/17/2008 | US20080014176 Method of inducing tolerance to betaap 1-42 and myelin basic protein |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | US20080014121 Analytical chip and analyzer |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | DE102006045391B4 Verfahren zur Nukleinsäure-Isolierung A method for nucleic acid isolation |
| 01/17/2008 | DE102006032634A1 Verfahren zur Herstellung von L-Aminosäuren A method for producing L-amino acids |
| 01/17/2008 | DE102006032424A1 Behandlung von T-Zell-Malignomen Treatment of T-cell malignancies |
| 01/17/2008 | CA2693630A1 Altering the fatty acid composition of rice |
| 01/17/2008 | CA2659103A1 Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 01/17/2008 | CA2658391A1 Dna encoding ring zinc-finger protein and the use of the dna in vectors and bacteria and in plants |
| 01/17/2008 | CA2658266A1 Non-replicating paramyxoviridae virus vector |
| 01/17/2008 | CA2657999A1 Photochemical internalization of sirna |
| 01/17/2008 | CA2657684A1 Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
| 01/17/2008 | CA2657648A1 Virosomes, methods of preparation, and immunogenic compositions |
| 01/17/2008 | CA2657385A1 Cell death inducer |
| 01/17/2008 | CA2657030A1 Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases |
| 01/17/2008 | CA2656786A1 Fatty acid desaturases and uses thereof |
| 01/17/2008 | CA2655764A1 Protein targeting to lipid bodies |
| 01/16/2008 | EP1878805A2 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 01/16/2008 | EP1878804A1 Perkinson disease-related gene grk5 and use thereof |
| 01/16/2008 | EP1878800A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight |
| 01/16/2008 | EP1878799A2 Methods of screening agents for activity using teleosts |
| 01/16/2008 | EP1878798A1 Method of producing a multichimeric mouse and applications to study the immunopathogenesis of human tissue-specific pathologies |
| 01/16/2008 | EP1878797A2 Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same |
| 01/16/2008 | EP1878796A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878795A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878794A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878792A1 Polynucleotides encoding caryophyllene synthase and uses thereof |
| 01/16/2008 | EP1878751A2 Single domain - Fc fusion constructs |
| 01/16/2008 | EP1878750A2 Single domain - Fc fusion constructs |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/16/2008 | EP1878439A2 Actinobacillus pleuropneumoniae virulence genes |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1878342A1 Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses |
| 01/16/2008 | EP1878337A1 Wheat containing novel starch and method of producing the same |
| 01/16/2008 | EP1877580A2 Lawsonia intracellularis immunological proteins |
| 01/16/2008 | EP1877575A1 System for producing synthetic promoters |
| 01/16/2008 | EP1877564A2 Interaction of glyphosate with photosystem ii inhibitor herbicides as a selection tool for roundup ready events |
| 01/16/2008 | EP1877563A2 Plants containing a heterologous flavohemoglobin gene and methods of use thereof |
| 01/16/2008 | EP1877562A1 High-phosphate starch |
| 01/16/2008 | EP1877561A1 Abfb-1 gene of penicillium funiculosum |
| 01/16/2008 | EP1877560A1 Abfb-2 gene of penicillium funiculosum |
| 01/16/2008 | EP1877559A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 01/16/2008 | EP1877558A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/16/2008 | EP1877557A2 Micro-rna's that regulate muscle cells |
| 01/16/2008 | EP1877556A2 USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN |
| 01/16/2008 | EP1877555A2 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure. |
| 01/16/2008 | EP1877554A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 01/16/2008 | EP1877552A2 O-acetylhomoserinesulfhydorelace gene and use thereof |
| 01/16/2008 | EP1877551A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 01/16/2008 | EP1877549A2 Hiv vaccine |
| 01/16/2008 | EP1877542A1 A method for producing stem cells or stem cell-like cells from mammalian embryos |
| 01/16/2008 | EP1877441A2 Method of producing human igg antibodies with enhanced effector functions |
| 01/16/2008 | EP1877431A1 Antiviral peptide against hepatitis c virus |
| 01/16/2008 | EP1877429A2 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| 01/16/2008 | EP1877421A2 Single-chain antibody with cleavable linker |
| 01/16/2008 | EP1877088A2 Vaccine against pandemic strains of influenza viruses |
| 01/16/2008 | EP1877084A2 Method for the isolation of spiroplasma in mammals |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1877070A2 Dosage of oligonucleotides |
| 01/16/2008 | EP1877069A2 Novel use of spiegelmers |
| 01/16/2008 | EP1877065A2 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 01/16/2008 | EP1877030A2 Duffy antigen receptor for chemokines and use thereof |
| 01/16/2008 | EP1876893A2 Cancer treatment by combined inhibition of proteasome and telomerase activities |
| 01/16/2008 | EP1704256A4 Detection and quantification of analytes in solution using polymers |
| 01/16/2008 | EP1649022A4 Wheat with altered branching enzyme activity and starch and starch containing products derived thereform |
| 01/16/2008 | EP1599231A4 Treatment of pain through expression of opioid receptors |
| 01/16/2008 | EP1537238B1 Method for quantitative determination of polynucleotides in a mixture |
| 01/16/2008 | EP1506316B1 Method for improving efficiencies in livestock production |
| 01/16/2008 | EP1457559B1 Artificial antibody library with super-repertory |
| 01/16/2008 | EP1383864B1 Isoprenoid production |
| 01/16/2008 | EP1351979B1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 01/16/2008 | EP1325142B1 Virus-based amplification vectors for plants |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1294940B1 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1228193B1 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1098961B1 Interferon inducing genetically engineered attenuated viruses |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | EP0991761B1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107522A Nucleic acid enzyme light-up sensor utilizing invasive DNA |
| 01/16/2008 | CN101107364A Plants having increased yield and a method for making the same |
| 01/16/2008 | CN101107363A Plants having improved growth characteristics and method for making the same |
| 01/16/2008 | CN101107362A Methods and materials for conferring resistance to pests and pathogens of plants |
| 01/16/2008 | CN101107361A Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 01/16/2008 | CN101107360A HCV F protein and uses thereof |
| 01/16/2008 | CN101107359A A method of prime-boost vaccination |
| 01/16/2008 | CN101107358A Nucleic acids for apoptosis of cancer cells |
| 01/16/2008 | CN101107357A Free reactant use in nucleic acid-templated synthesis |
| 01/16/2008 | CN101107356A Method of enzymatically synthesizing 3'-phosphoadenosine-5'-phosphosulfate |
| 01/16/2008 | CN101107355A A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family having a pathway of glycogen biosynthesis disrupted |